The characteristics of Barrett's esophagus: An analysis of 4120 cases in China

Diseases of the Esophagus

Volumn 22, Issue 4, 2009, Pages 348-353

  Chen, Xia ^a   Zhu, Liang Ru ^a   Hou, Kiao Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Barrett Esophagus (BE); Clinico pathological characteristics; Endoscopic characteristics; Follow up

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ADOLESCENT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; CHINA; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; YOUNG ADULT;

EID: 65949089629     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00924.x     Document Type: Article

References (42)

1. Moghissi K, Sharpe D A, Pender D. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg 1993; 7: 126-31.
2. Van Laethem J L, Peny M O, Salmon I et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000; 46: 574-7.
3. Shaheen N, Ransohoff D F. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: Scientific review. JAMA 2002; 287: 1972-81.
4. Zagorowicz E, Jankowski J. Molecular changes in the progression of Barrett's oesophagus. Postgrad Med J 2007; 83: 529-35.
5. Bytzer P, Christensen P B, Damkier P et al. Adenocarcinoma of the esophagus and Barrett's esophagus: A population-based study. Am J Gastroenterol 1999; 94: 86-91.
6. Hou X H, Zheng L D, Wang D R. The aetiology and epidemiology of Barrett's esophagus in China. Chin J Dig 2006; 26: 114-15.
7. Li Y M, Du J, Zhang H et al. Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China. J Gastroenterol Hepatol 2008; 23: 283-9.
8. Vakil N, van Zanten S V, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20, quiz 43.
9. Stroup D F, Berlin J A, Morton S C et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
10. Herlihy K J, Orlando R C, Bryson J C et al. Barrett's esophagus: clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics. Gastroenterology 1984; 86: 436-43.
11. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004; 127: 310-30.
12. Belladonna J A, Hajdu S I, Bains M S et al. Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology. N Engl J Med 1974; 291: 895-6.
13. Lagarde S M, ten Kate F J, Reitsma J B et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 24: 4347-55.
14. Cossentino M J, Wong R K. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 2003; 14: 128-35.
15. Wong A, Fitzgerald R C. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005; 3: 1-10.
16. Tytgat G N, Bartelink H, Bernards R et al. Cancer of the esophagus and gastric cardia: Recent advances. Dis Esophagus 2004; 17: 10-26.
17. Souza R F, Spechler S J. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 2005; 55: 334-51.
18. Casson A G, Williams L, Guernsey D L. Epidemiology and molecular biology of Barrett esophagus. Semin Thorac Cardiovasc Surg 2005; 17: 284-91.
19. Ford A C, Forman D, Reynolds P D et al. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005; 162: 454-60.
20. Chen M, Xiong L, Chen H et al. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: A population-based study in South China. Scand J Gastroenterol 2005; 40: 759-67.
21. Caygill C P, Watson A, Reed P I et al. Characteristics and regional variations of patients with Barrett's oesophagus in the UK. Eur J Gastroenterol Hepatol 2003; 15: 1217-22.
22. Csendes A, Smok G, Quiroz J et al. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 2002; 97: 554-60.
23. Qureshi W A, Wu J, Demarco D et al. Capsule endoscopy for screening for short-segment Barrett's esophagus. Am J Gastroenterol 2008; 103: 533-7.
24. Hirota W K, Loughney T M, Lazas D J et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
25. Yagi K, Nakamura A, Sekine A et al. Endoscopic findings of adenocarcinoma arising from short-segment Barrett's esophagus. J Gastroenterol Hepatol 2004; 19: 940-3.
26. May A, Gossner L, Pech O et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002; 34: 604-10.
27. Spechler S J. Guidelines for managing short-segment Barrett's esophagus. Am J Manag Care 2000; 6: S891-4.
28. Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
29. Avidan B, Sonnenberg A, Schnell T G et al. There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: Endoscopic diagnosis is still essential. Aliment Pharmacol Ther 2002; 16: 735-42.
30. Gerson L B, Edson R, Lavori P W et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001; 96: 2005-12.
31. Caum L C, Bizinelli S L, Pisani J C et al. Specialized intestinal metaplasia of the distal esophagus in gastroesophageal reflux disease: prevalence and clinico-demographic features. Arq Gastroenterol 2003; 40: 220-6.
32. Csendes A, Smok G, Burdiles P et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus 2003; 16: 24-8.
33. Weston A P, Krmpotich P T, Cherian R et al. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci 1997; 42: 597-602.
34. Weston A P, Badr A S, Topalovski M et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-94.
35. Abe Y, Ohara S, Koike T et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 2004; 99: 1213-21.
36. Brown L M, Thomas T L, Ma J L et al. Helicobacter pylori infection in rural China: Demographic, lifestyle and environmental factors. Int J Epidemiol 2002; 31: 638-45.
37. Ferrandez A, Benito R, Arenas J etal. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 2006; 6: 7.
38. Riddell R H. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol 1996; 91: 853-63.
39. Farrow D C, Vaughan T L. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996; 7: 322-7.
40. Conio M, Blanchi S, Lapertosa G et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol 2003; 98: 1931-9.
41. Skacel M, Petras R E, Gramlich T L et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95: 3383-7.
42. Sharma P. Low-grade dysplasia in Barrett's esophagus. Gastroenterology 2004; 127: 1233-8.